The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome

June 23, 2025 updated by: Esra KARATAŞ OKYAY, Kahramanmaras Sutcu Imam University

The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome: A Randomized Controlled Study

Mandala practice will be applied to women with premenstrual syndrome. The intervention group (Mandala practice group) and the control group each consisted of 60 women.

Study Overview

Status

Completed

Detailed Description

Materials and Methods: The randomized controlled trial was conducted between October 2022 and April 2024 with 120 students (60 intervention group and 60 control group) studying at Kahramanmaraş Sütçü İmam University and Gaziantep Islamic Science and Technology University, Faculty of Health Sciences, Department of Midwifery. In the study, mandala art therapy is applied to the students in the intervention group. The students will be informed about the method to be followed in the research, the voluntary information form will be read to those who want to participate in the research, and their verbal and written permission will be obtained. Before the mandala art therapy, Personal Information Form, Premenstrual Syndrome Scale (PMSS), Coping with Premenstrual Change Scale, Perceived Stress Scale, Beck Depression Inventory will be applied to the students in both groups. The students in the intervention group will be given mandala activity by the researcher two days a week for 12 weeks/total 24 times. Three months after the first interview, Premenstrual Syndrome Scale (PMSÖ), Coping with Premenstrual Change Scale, Perceived Stress Scale, Beck Depression Inventory will be administered as a post-test. One month after the end of the study, Premenstrual Syndrome Scale (PMS), Coping with Premenstrual Change Scale, Perceived Stress Scale, Beck Depression Inventory will be administered again as follow-up assessment. The materials such as drawing paper, drawing and crayons required for mandala drawing in the study were provided by the researchers.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gaziantep, Turkey
        • Gaziantep Islamic University of Science and Technology
      • Kahramanmaraş, Turkey
        • Kahramanmaraş Sütçü İmam University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being between the ages of 18-45
  • Having a regular menstrual history between 21-35 days
  • Score above 110 on the PMSÖ
  • Not taking medical treatment for PMS,
  • No history of psychiatric illness,
  • No gynecological disease,
  • No recent use of antidepressants, benzodiazepines/antipsychotics, combined oral contraceptives or hormones,
  • Volunteering to participate in the study.
  • Not having received mandala art therapy training before,
  • Not having a physical problem that would prevent mandala production,
  • Active use of hands,
  • No communication problems,
  • Speaking Turkish,
  • Suitability/willingness to work in a group.

Exclusion Criteria:

  • Having a diagnosis of psychiatric illness
  • Having a diagnosis of chronic disease
  • History of drug use
  • Under 18 years of age
  • Unable to communicate verbally,
  • Giving birth in the last 3 months or breastfeeding,
  • Pregnant,
  • Have a history of psychiatric illness (diagnosis of moderate or severe depression, psychosis, bipolar illness, eating disorder, somatic symptom disorder, or acute suicidality),
  • Gynecological disease (e.g. hysterectomy, oophorectomy, gynecological cancer, polycystic ovary syndrome, infertility, endometriosis)
  • Recent use of antidepressants, benzodiazepines/antipsychotics, combined oral contraceptives or hormones,
  • Having a physical problem that prevents you from creating a mandala,
  • The student has a physical disability in the upper extremity,
  • Previous mandala art therapy training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention (Mandala art therapy) group
Students with premenstrual syndrome who were included in the mandala art therapy group by randomization method will be made to practice mandala.
Personal Information Form, Premenstrual Syndrome Scale, Coping with Premenstrual Change Scale, Perceived Stress Scale, Beck Depression Inventory will be applied to the students in both groups before mandala art therapy. The students in the experimental group will be given mandala activity by the researcher two days a week for 12 weeks/total 24 times. Three months after the first interview, Premenstrual Syndrome Scale, Coping with Premenstrual Change Scale, Perceived Stress Scale, Beck Depression Inventory will be administered as a post-test. One month after the end of the study, Premenstrual Syndrome Scale, Coping with Premenstrual Change Scale, Perceived Stress Scale, Beck Depression Inventory will be applied again as follow-up evaluation.
No Intervention: Control
Control group is the group without any intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determining the level of premenstrual syndrome
Time Frame: At the first interview, the Premenstrual Syndrome Scale was applied to all students in both groups as a pre-test.
It is a five-point Likert-type scale consisting of 44 questions measuring the severity of premenstrual symptoms. The scale has a total of nine sub-dimensions including Depressive Affect, Anxiety, Fatigue, Irritability, Depressive Thoughts, Pain, Appetite Changes, Sleep Changes, and Bloating. The application of the premenstrual syndrome scale is carried out by retrospectively evaluating the person by taking into account the status of "being within one week before menstruation". "PMSQ Total Score" is obtained from the sum of the scores obtained from all sub-dimensions. A minimum of 44 and a maximum of 220 points can be obtained from the scale. An increase in the score indicates an increase in the intensity of PMS symptoms.
At the first interview, the Premenstrual Syndrome Scale was applied to all students in both groups as a pre-test.
Determining the level of premenstrual syndrome
Time Frame: Three months after the first interview, the Premenstrual Syndrome Scale is administered as a pre-test to all students in both groups.
It is a five-point Likert-type scale consisting of 44 questions measuring the severity of premenstrual symptoms. The scale has a total of nine sub-dimensions including Depressive Affect, Anxiety, Fatigue, Irritability, Depressive Thoughts, Pain, Appetite Changes, Sleep Changes, and Bloating. The application of the premenstrual syndrome scale is carried out by retrospectively evaluating the person by taking into account the status of "being within one week before menstruation". "PMSQ Total Score" is obtained from the sum of the scores obtained from all sub-dimensions. A minimum of 44 and a maximum of 220 points can be obtained from the scale. An increase in the score indicates an increase in the intensity of PMS symptoms.
Three months after the first interview, the Premenstrual Syndrome Scale is administered as a pre-test to all students in both groups.
Determining the level of premenstrual syndrome
Time Frame: One month after the post-test, the Premenstrual Syndrome Scale is administered to all students in both groups as a follow-up assessment.
It is a five-point Likert-type scale consisting of 44 questions measuring the severity of premenstrual symptoms. The scale has a total of nine sub-dimensions including Depressive Affect, Anxiety, Fatigue, Irritability, Depressive Thoughts, Pain, Appetite Changes, Sleep Changes, and Bloating. The application of the premenstrual syndrome scale is carried out by retrospectively evaluating the person by taking into account the status of "being within one week before menstruation". "PMSQ Total Score" is obtained from the sum of the scores obtained from all sub-dimensions. A minimum of 44 and a maximum of 220 points can be obtained from the scale. An increase in the score indicates an increase in the intensity of PMS symptoms.
One month after the post-test, the Premenstrual Syndrome Scale is administered to all students in both groups as a follow-up assessment.
Identifying Coping with Premenstrual Change
Time Frame: At the first interview, the Coping with Premenstrual Change Scale was applied to all students in both groups as a pre-test.
"Coping with Premenstrual Change Scale (PMS-Coping)" It has 17 items and three sub-dimensions (Seeking Positive Affecting Behaviors, Seeking Support, Health Care Utilization Behavior). The items of the scale are answered on a 4-point Likert scale. The scale includes the options of "strongly disagree" (1 point), "not sure" (2 points), "agree" (3 points) and "strongly agree" (4 points). The minimum score is 17 and the maximum score is 68. In the instructions of the scale, it is asked to answer by thinking about the days before menstruation starts. The scale is used to describe the methods used to cope with premenstrual change in women.
At the first interview, the Coping with Premenstrual Change Scale was applied to all students in both groups as a pre-test.
Identifying Coping with Premenstrual Change
Time Frame: Three months after the first interview, the Coping with Premenstrual Change Scale is administered as a pre-test to all students in both groups.
"Coping with Premenstrual Change Scale (PMS-Coping)" It has 17 items and three sub-dimensions (Seeking Positive Affecting Behaviors, Seeking Support, Health Care Utilization Behavior). The items of the scale are answered on a 4-point Likert scale. The scale includes the options of "strongly disagree" (1 point), "not sure" (2 points), "agree" (3 points) and "strongly agree" (4 points). The minimum score is 17 and the maximum score is 68. In the instructions of the scale, it is asked to answer by thinking about the days before menstruation starts. The scale is used to describe the methods used to cope with premenstrual change in women.
Three months after the first interview, the Coping with Premenstrual Change Scale is administered as a pre-test to all students in both groups.
Identifying Coping with Premenstrual Change
Time Frame: One month after the post-test, the Coping with Premenstrual Change Scale is administered to all students in both groups as a follow-up assessment.
"Coping with Premenstrual Change Scale (PMS-Coping)" It has 17 items and three sub-dimensions (Seeking Positive Affecting Behaviors, Seeking Support, Health Care Utilization Behavior). The items of the scale are answered on a 4-point Likert scale. The scale includes the options of "strongly disagree" (1 point), "not sure" (2 points), "agree" (3 points) and "strongly agree" (4 points). The minimum score is 17 and the maximum score is 68. In the instructions of the scale, it is asked to answer by thinking about the days before menstruation starts. The scale is used to describe the methods used to cope with premenstrual change in women.
One month after the post-test, the Coping with Premenstrual Change Scale is administered to all students in both groups as a follow-up assessment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determination of Perceived Stress Level
Time Frame: At the first interview, the Perceived Stress Level Scale was applied to all students in both groups as a pre-test.
The Perceived Stress Level Scale (PSL) consists of 14 items. It was created to measure the extent to which people perceive certain situations in their lives as stressful. The scale is a 5-point Likert-type scale (0: Never, 1: Almost Never, 2: Sometimes, 3: Frequently, 4: Very often). The questions in the scale are aimed at evaluating the change in the participants' emotional state in the last one month. The stress level perceived by the respondent is determined by summing the scores obtained from the items. The scale has a total score between 0-56 points and the higher the score, the higher the perceived stress level.
At the first interview, the Perceived Stress Level Scale was applied to all students in both groups as a pre-test.
Determination of Perceived Stress Level
Time Frame: Three months after the first interview, the Perceived Stress Level Scale is administered as a pre-test to all students in both groups.
The Perceived Stress Level Scale (PSL) consists of 14 items. It was created to measure the extent to which people perceive certain situations in their lives as stressful. The scale is a 5-point Likert-type scale (0: Never, 1: Almost Never, 2: Sometimes, 3: Frequently, 4: Very often). The questions in the scale are aimed at evaluating the change in the participants' emotional state in the last one month. The stress level perceived by the respondent is determined by summing the scores obtained from the items. The scale has a total score between 0-56 points and the higher the score, the higher the perceived stress level.
Three months after the first interview, the Perceived Stress Level Scale is administered as a pre-test to all students in both groups.
Determination of Perceived Stress Level
Time Frame: One month after the post-test, the Perceived Stress Level Scale is administered to all students in both groups as a follow-up assessment.
The Perceived Stress Level Scale (PSL) consists of 14 items. It was created to measure the extent to which people perceive certain situations in their lives as stressful. The scale is a 5-point Likert-type scale (0: Never, 1: Almost Never, 2: Sometimes, 3: Frequently, 4: Very often). The questions in the scale are aimed at evaluating the change in the participants' emotional state in the last one month. The stress level perceived by the respondent is determined by summing the scores obtained from the items. The scale has a total score between 0-56 points and the higher the score, the higher the perceived stress level.
One month after the post-test, the Perceived Stress Level Scale is administered to all students in both groups as a follow-up assessment.
Determination of Depression Level
Time Frame: At the first interview, the Beck Depression Inventory was applied to all students in both groups as a pre-test.
The Depression Inventory consists of 21 items, 15 of which include psychological and 6 somatic symptoms. Although the inventory is a 4-point Likert-type inventory (scored between 0-3), it is used in various researches and clinical applications. The highest score that can be obtained from the inventory is 63 and the lowest score is 0. A high total score indicates a high level of depression. The cut-off point for clinical significance of depression is 17 points.
At the first interview, the Beck Depression Inventory was applied to all students in both groups as a pre-test.
Determination of Depression Level
Time Frame: Three months after the first interview, the Beck Depression Inventory is administered as a pre-test to all students in both groups.
The Depression Inventory consists of 21 items, 15 of which include psychological and 6 somatic symptoms. Although the inventory is a 4-point Likert-type inventory (scored between 0-3), it is used in various researches and clinical applications. The highest score that can be obtained from the inventory is 63 and the lowest score is 0. A high total score indicates a high level of depression. The cut-off point for clinical significance of depression is 17 points.
Three months after the first interview, the Beck Depression Inventory is administered as a pre-test to all students in both groups.
Determination of Depression Level
Time Frame: One month after the post-test, the Beck Depression Inventory is administered to all students in both groups as a follow-up assessment.
The Depression Inventory consists of 21 items, 15 of which include psychological and 6 somatic symptoms. Although the inventory is a 4-point Likert-type inventory (scored between 0-3), it is used in various researches and clinical applications. The highest score that can be obtained from the inventory is 63 and the lowest score is 0. A high total score indicates a high level of depression. The cut-off point for clinical significance of depression is 17 points.
One month after the post-test, the Beck Depression Inventory is administered to all students in both groups as a follow-up assessment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Esra KARATAŞ OKYAY, Kahramanmaraş Sütçü İmam University
  • Study Director: Zeynep BAL, PhD, Gaziantep Islam Science and Technology University
  • Study Director: Hatice POLAT, PhD, Malatya Turgut Ozal University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2022

Primary Completion (Actual)

April 29, 2024

Study Completion (Actual)

April 30, 2024

Study Registration Dates

First Submitted

November 16, 2023

First Submitted That Met QC Criteria

November 16, 2023

First Posted (Actual)

November 22, 2023

Study Record Updates

Last Update Posted (Actual)

June 26, 2025

Last Update Submitted That Met QC Criteria

June 23, 2025

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • KSUESRAKARATASOKYAY002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

we don't share individual participant data with other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premenstrual Syndrome

Clinical Trials on Intervention (Mandala art therapy) group

Subscribe